Search filters

List of works by Jenny Byrne

A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical course

article

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

scientific article published on 10 January 2020

A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation

scientific article published on 22 May 2006

Adjuvant alpha-interferon improves complete remission rates following allogeneic transplantation for multiple myeloma

scientific article published on 01 October 1998

Allogeneic haemopoietic stem cell transplantation for multiple myeloma or plasma cell leukaemia using fractionated total body radiation and high-dose melphalan conditioning.

scientific article

Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT

scientific article published on 30 July 2019

Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

scientific article published on 28 March 2017

Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens.

scientific article published on October 2002

Allogeneic transplantation for multiple myeloma: late relapse may occur as localised lytic lesion/plasmacytoma despite ongoing molecular remission

scientific article published on 01 February 2003

Autologous GVHD following PBSCT, with evidence for a graft-versus-myeloma effect

article

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

scientific article published on 11 September 2003

CMV infection following nonmyeloablative allogeneic stem cell transplantation using Campath

scientific article published on 01 November 2002

Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution

scientific article published on 01 April 2002

Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation

scientific article published on 27 October 2014

Chromosomal abnormalities in Ph- cells of patients on imatinib

scientific article published in October 2003

Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak

scientific article published on 26 March 2007

Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMT

scientific article published on 02 May 2020

Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation.

scientific article

De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trial.

scientific article published on 26 May 2017

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability.

scientific article published in June 2002

Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation.

scientific article published in September 2005

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.

scientific article published on 11 November 2013

EBV-driven relapse of peripheral T-cell lymphoma, masquerading as a post transplant lymphoproliferative disorder following allo-SCT.

scientific article

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

scientific article

Expert radiological review of skeletal surveys identifies additional abnormalities in 23% of cases: further evidence for the value of myeloma multi-disciplinary teams in the accurate staging and treatment of myeloma patients

scientific article published on 01 April 2007

High dose melphalan or intermediate dose melphalan can be well tolerated and result in good response rates in selected elderly patients with myeloma

article by Mark Bishton et al published 26 February 2007 in Leukemia Research

High-dose melphalan followed by radical radiotherapy for the treatment of massive plasmacytoma of the chest wall

scientific article published on 01 October 2003

High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplant ⬇️

scientific article published on 15 September 2016

Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease

scientific article published on 01 March 2007

Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions.

scientific article published on 15 May 2003

Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission

scientific article published on 30 October 2009

Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow Transplantation study

scientific article published on 6 October 2014

In vivo Campath for the prevention of GvHD following allogeneic HSCT: effects of dose, schedule and antibody type

scientific article published on 01 December 2004

Incidence and management of hepatic severe veno-occlusive disease in 273 patients in a single centre with defibrotide

scientific article published on 25 April 2016

Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: evidence for a 'graft vs. myelofibrosis' effect

scientific article published on 01 February 2000

Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphoma

scientific article published on 18 March 2014

Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab

scientific article published on 01 June 2007

Low dose erythropoietin is effective in reducing transfusion requirements following allogeneic HSCT.

scientific article published in December 2005

Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis

scientific article published on 01 September 1998

Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease

scientific article published on 01 October 1999

Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission

scientific article published in November 2003

Opsoclonus myoclonus following allogeneic haematopoietic stem cell transplantation

scientific article published on 01 November 2005

Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results

scientific article published on 27 March 2014

Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes.

scientific article published on March 2004

Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.

scientific article published on 3 March 2008

Outcome of allografting for AML-CR2 is equivalent across BSBMT and EBMT and is associated with encouraging OS and DFS across all age groups

scientific article published on 24 January 2019

Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia

scientific article published on 19 May 2008

Pepperpot or not?

scientific article published on 15 June 2013

Peripheral blood stem cell transplants.

scientific article published on May 1998

Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

scientific article

Post-transplant lymphoproliferative disease following reduced intensity conditioning transplants incorporating alemtuzumab

scientific article published on 19 May 2008

Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia

scientific article published on 19 September 2007

Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity

article

Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML

scientific article published on 13 March 2020

Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative

scientific article published on 24 March 2020

Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantat

scientific article published on 11 July 2011

Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed

scientific article published on 22 August 2011

Stem cell mobilisation in lymphoproliferative diseases

scientific article published on 01 November 1998

Successful engraftment of a second transplant using non-myeloablative conditioning as treatment for graft failure following unrelated donor BMT

scientific article published on 01 March 2001

The acute impact of a hematopoietic allograft on lung function and inflammation: a prospective observational study.

scientific article

The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.

scientific article published in February 2000

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF).

scientific article

The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants.

scientific article

The molecular pathophysiology of myeloid leukaemias: Ras revisited.

scientific article published on February 1998

Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

scientific article published on 9 September 2015

Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.

scientific article published on 8 March 2011

Uptake of high-dose therapy and peripheral blood stem cell transplantation in myeloma patients <65 years--the role of the myeloma multi-disciplinary team

scientific article published on 01 July 2005

Use of haemopoietic growth factors: commentary on the ASCO/ECOG guidelines. American Society of Clinical Oncology/Eastern Co-operative Oncology Group.

scientific article published on March 1997

Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia.

scientific article

Paulina is supported by:

About Paulina

Help